Browse hierarchy: [Immunology (IM)](/submissions/IM) → [Subpart F — Immunological Test Systems](/submissions/IM/subpart-f%E2%80%94immunological-test-systems) → [21 CFR 866.5090](/submissions/IM/subpart-f%E2%80%94immunological-test-systems/866.5090) → NRI — Autoantibodies, Nuclear Pore Glycoprotein Gp210

# NRI · Autoantibodies, Nuclear Pore Glycoprotein Gp210

_Immunology · 21 CFR 866.5090 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/NRI

## Overview

- **Product Code:** NRI
- **Device Name:** Autoantibodies, Nuclear Pore Glycoprotein Gp210
- **Regulation:** [21 CFR 866.5090](/submissions/IM/subpart-f%E2%80%94immunological-test-systems/866.5090)
- **Device Class:** 2
- **Review Panel:** [Immunology](/submissions/IM)
- **3rd-party reviewable:** yes

## Identification

An antimitochondrial antibody immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the antimitochondrial antibodies in human serum. The measurements aid in the diagnosis of diseases that produce a spectrum of autoantibodies (antibodies produced against the body's own tissue), such as primary biliary cirrhosis (degeneration of liver tissue) and chronic active hepatitis (inflammation of the liver).

## Classification Rationale

Class II (performance standards).

## Recent Cleared Devices (2 of 2)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K061842](https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/NRI/K061842.md) | QUANTA LITE PBC SCREEN IGG/IGA ELISA | Inova Diagnostics, Inc. | Oct 18, 2006 | SESE |
| [K040885](https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/NRI/K040885.md) | QUANTA LITE GP210 ELISA | Inova Diagnostics, Inc. | Jun 25, 2004 | SESE |

## Top Applicants

- Inova Diagnostics, Inc. — 2 clearances

---

**Source:** [https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/NRI](https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/NRI)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com